Current recommendations for HCC screening, as endorsed by professional society guidelines, include semi-annual abdominal ultrasound with or without serum alpha-fetoprotein (AFP) for patients with cirrhosis and subgroups with chronic hepatitis B virus infection 28. The gene discussed is AFP; the disease is hepatocellular carcinoma.